학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 57건 | 목록 1~20
Academic Journal
Hamdy FC; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK. Freddie.Hamdy@nds.ox.ac.uk.; Oxford University Hospitals NHS Trust, Oxford, UK. Freddie.Hamdy@nds.ox.ac.uk.; Lamb AD; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Tullis IDC; Department of Oncology, University of Oxford, Oxford, UK.; Verrill C; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Rombach I; Oxford Clinical Trials Research Unit and Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; University of Sheffield, School of Medicine and Population Health, Sheffield, UK.; Rao SR; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Colling R; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Barber PR; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Volpi D; Department of Oncology, University of Oxford, Oxford, UK.; Barbera-Martin L; Oxford University Hospitals NHS Trust, Oxford, UK.; Lopez JF; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Omer A; Oxford University Hospitals NHS Trust, Oxford, UK.; Hewitt A; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Lovell S; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Niederer J; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Lambert A; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Snoeck J; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Thomson C; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Leslie T; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Bryant RJ; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Headington, Oxford, OX3 7DQ, UK.; Oxford University Hospitals NHS Trust, Oxford, UK.; Mascioni A; ImaginAb, Inc, Inglewood, CA, USA.; Jia F; ImaginAb, Inc, Inglewood, CA, USA.; Torgov M; ImaginAb, Inc, Inglewood, CA, USA.; Wilson I; ImaginAb, Inc, Inglewood, CA, USA.; Gudas J; ImaginAb, Inc, Inglewood, CA, USA.; Wu AM; Beckman Research Institute, City of Hope, Duarte, CA, 91010, USA.; Olafsen T; Beckman Research Institute, City of Hope, Duarte, CA, 91010, USA.; Vojnovic B; Department of Oncology, University of Oxford, Oxford, UK.
Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
Academic Journal
Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Mustapha R; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Flores-Borja F; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Alfano G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Ng K; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Weitsman G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Dolcetti L; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Suwaidan AA; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Wong F; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Vicencio JM; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Galazi M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Opzoomer JW; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Arnold JN; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Thavaraj S; Centre for Clinical, Oral & Translational Science, King's College London, London, United Kingdom.; Kordasti S; Systems Cancer Immunology, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Doyle J; Daiichi Sankyo Incorporated, Newark, United States.; Greenberg J; Daiichi Sankyo Incorporated, Newark, United States.; Dillon MT; The Institute of Cancer Research, London, United Kingdom.; Harrington KJ; The Institute of Cancer Research, London, United Kingdom.; Forster M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Coolen ACC; Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom.; Saddle Point Science Ltd, London, United Kingdom.; Ng T; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Hertweck A; UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, WC1E 6BT, UK.; Vila de Mucha M; UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, WC1E 6BT, UK.; Barber PR; UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, WC1E 6BT, UK.; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 1UL, UK.; Dagil R; Research Department of Structural and Molecular Biology, University College London, Darwin Building, Gower Street, London, WC1E 6XA, UK.; Porter H; UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, WC1E 6BT, UK.; Ramos A; Research Department of Structural and Molecular Biology, University College London, Darwin Building, Gower Street, London, WC1E 6XA, UK.; Lord GM; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9NT, UK.; Jenner RG; UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, WC1E 6BT, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE
Academic Journal
Vicencio JM; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK. j.vicencio@ucl.ac.uk.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK. j.vicencio@ucl.ac.uk.; Evans R; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Green R; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; An Z; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Deng J; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Treacy C; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Mustapha R; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Monypenny J; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Costoya C; Cancer Immunology Unit, Cancer Institute, University College London, London, UK.; Lawler K; Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.; Ng K; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; De-Souza K; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Coban O; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Gomez V; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Clancy J; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Chen SH; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Chalk A; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Wong F; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Gordon P; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Savage C; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Gomes C; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Pan T; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Alfano G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Dolcetti L; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Chan JNE; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Flores-Borja F; Centre for Immunobiology and Regenerative Medicine, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Barber PR; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Weitsman G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Sosnowska D; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Capone E; Department of Innovative Technologies in Medicine & Dentistry, University of Chieti-Pescara, Center for Advanced Studies and Technology (CAST), Chieti, Italy.; Iacobelli S; MediaPharma SRL, Chieti, Italy.; Hochhauser D; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Hartley JA; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Parsons M; Randall Centre for Cell and Molecular Biophysics, King's College London, London, UK.; Arnold JN; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Ameer-Beg S; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Quezada SA; Cancer Immunology Unit, Cancer Institute, University College London, London, UK.; Yarden Y; Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.; Sala G; Department of Innovative Technologies in Medicine & Dentistry, University of Chieti-Pescara, Center for Advanced Studies and Technology (CAST), Chieti, Italy.; Ng T; Molecular Oncology Group, Cancer Institute, Paul O'Gorman Building, University College London, London, UK. tony.ng@kcl.ac.uk.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK. tony.ng@kcl.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Academic Journal
Balukova A; Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London NW3 2QG, UK.; Bokea K; Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London NW3 2QG, UK.; Barber PR; Department of Oncology, UCL Cancer Institute, University College London, London WC1E 6DD, UK.; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.; Ameer-Beg SM; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.; MacRobert AJ; Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London NW3 2QG, UK.; Yaghini E; Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London NW3 2QG, UK.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Academic Journal
Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Timms JA; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Blighe K; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Mourikis TP; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Chapuis N; Institut Cochin, Institut National de la Santé et de la Recherche Médicale U1016, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8104, Université Paris Descartes, Paris, France.; Bekoe R; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Kareemaghay S; Centre for Host Microbiome Interaction, FoDOCS, King's College, Guy's Hospital, London, United Kingdom.; Nocerino P; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Apollonio B; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Ramsay AG; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Tavassoli M; Centre for Host Microbiome Interaction, FoDOCS, King's College, Guy's Hospital, London, United Kingdom.; Harrison C; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Haematology Department, Guy's Hospital, London, United Kingdom.; Ciccarelli F; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Cancer Systems Biology Laboratory, The Francis Crick Institute, London, United Kingdom.; Parker P; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Francis Crick Institute, London, United Kingdom.; Fontenay M; Institut Cochin, Institut National de la Santé et de la Recherche Médicale U1016, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8104, Université Paris Descartes, Paris, France.; Barber PR; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Kordasti S; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Haematology Department, Guy's Hospital, London, United Kingdom.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Gao D; Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin, Madison, WI, United States of America.; Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Chacko JV; Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin, Madison, WI, United States of America.; Kader Sagar MA; Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin, Madison, WI, United States of America.; Department of Biomedical Engineering, University of Wisconsin, Madison, WI, United States of America.; Rueden CT; Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin, Madison, WI, United States of America.; Grislis AR; Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin, Madison, WI, United States of America.; Hiner MC; Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin, Madison, WI, United States of America.; Eliceiri KW; Laboratory for Optical and Computational Instrumentation, Center for Quantitative Cell Imaging, University of Wisconsin, Madison, WI, United States of America.; Department of Biomedical Engineering, University of Wisconsin, Madison, WI, United States of America.; Department of Medical Physics, University of Wisconsin, Madison, WI, United States of America.; Morgridge Institute for Research, University of Wisconsin, Madison, WI, United States of America.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Gómez V; UCL Cancer Institute, University College London, London WC1E 6DD, UK. tony.ng@kcl.ac.uk valentin.gomez@ucl.ac.uk.; Eykyn TR; School of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.; Mustapha R; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK.; Flores-Borja F; KCL Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London SE1 1UL, UK.; Male V; Institute of Immunity and Transplantation, Royal Free Hospital, University College London, London NW3 2QG, UK.; Barber PR; UCL Cancer Institute, University College London, London WC1E 6DD, UK.; Patsialou A; UCL Cancer Institute, University College London, London WC1E 6DD, UK.; Green R; KCL Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London SE1 1UL, UK.; Panagaki F; School of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.; Li CW; School of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.; Fruhwirth GO; School of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.; Ros S; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK.; Brindle KM; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK.; Ng T; UCL Cancer Institute, University College London, London WC1E 6DD, UK. tony.ng@kcl.ac.uk valentin.gomez@ucl.ac.uk.; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK.; KCL Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London SE1 1UL, UK.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101465400 Publication Model: Electronic Cited Medium: Internet ISSN: 1937-9145 (Electronic) Linking ISSN: 19450877 NLM ISO Abbreviation: Sci Signal Subsets: MEDLINE
Academic Journal
Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Weitsman G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Lawler K; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Institute for Mathematical and Molecular Biomedicine, King's College London, Guy's Medical School Campus, London, UK.; Barrett JE; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Rowley M; Institute for Mathematical and Molecular Biomedicine, King's College London, Guy's Medical School Campus, London, UK.; Saddle Point Science Ltd, London, UK.; Rodriguez-Justo M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Fisher D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; Gao F; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Tullis IDC; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Deng J; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Brown L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; Kaplan R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.; Hochhauser D; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Adams R; School of Medicine, Cardiff University, Cardiff, UK.; Maughan TS; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Vojnovic B; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Coolen ACC; Institute for Mathematical and Molecular Biomedicine, King's College London, Guy's Medical School Campus, London, UK.; Saddle Point Science Ltd, London, UK.; Ng T; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, UK.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital King's College London, London, UK.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Academic Journal
Singh AN; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Oehler J; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Torrecilla I; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Kilgas S; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Li S; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Vaz B; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Guérillon C; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.; Fielden J; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Hernandez-Carralero E; Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.; Cabrera E; Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.; Tullis ID; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Meerang M; Institute of Pharmacology and Toxicology-Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.; Barber PR; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Freire R; Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.; Universidad Fernando Pessoa Canarias, Santa Maria de Guia, Spain.; Parsons J; Department of Molecular and Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, Liverpool, UK.; Vojnovic B; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Kiltie AE; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.; Mailand N; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.; Ramadan K; Department of Oncology, Cancer Research UK/Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE
Academic Journal
Propper DJ; Barts Cancer Institute, Queen Mary, University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.; Gao F; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Saunders MP; The Christie, Manchester, M20 4BX, UK.; Sarker D; School of Cancer and Pharmaceutical Sciences, King's College London, London, WC2R 2LS, UK.; Hartley JA; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Spanswick VJ; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Lowe HL; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Hackett LD; UCL ECMC GCLP Facility, UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Ng TT; Barts Cancer Institute, Queen Mary, University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Breast Cancer Now Research Unit, Department of Research Oncology, Guy's Hospital, King's College London, London, SE1 9RT, UK.; Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Weitsman GE; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, SE1 1UL, UK.; Pearce S; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, W1T 4TJ, UK.; White L; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, W1T 4TJ, UK.; Lopes A; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, W1T 4TJ, UK.; Forsyth S; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, W1T 4TJ, UK.; Hochhauser D; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK. d.hochhauser@ucl.ac.uk.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Academic Journal
Gómez V; UCL Cancer Institute, University College London, London, United Kingdom.; Galazi M; UCL Cancer Institute, University College London, London, United Kingdom.; Weitsman G; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Monypenny J; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Al-Salemee F; School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.; Barber PR; UCL Cancer Institute, University College London, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Ng K; UCL Cancer Institute, University College London, London, United Kingdom.; Beatson R; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Szokol B; Vichem Chemie Ltd., Veszprém, Hungary.; Orfi L; Vichem Chemie Ltd., Veszprém, Hungary.; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary.; Mullen G; School of Biomedical Engineering & Imaging Sciences, King's College London, London, United Kingdom.; Vanhaesebroeck B; UCL Cancer Institute, University College London, London, United Kingdom.; Chowdhury S; Guy's, King's, and St. Thomas' Hospitals, and Sarah Cannon Research Institute, London, United Kingdom.; Leung HY; Cancer Research United Kingdom Beatson Institute, Bearsden, Glasgow, United Kingdom.; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Bearsden, Glasgow, United Kingdom.; Ng T; UCL Cancer Institute, University College London, London, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One
Academic Journal
Rowley MI; Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom.; Coolen AC; Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom.; Vojnovic B; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Barber PR; Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom.; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Weill Cornell Medical College, New York, New York.; Michelini F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Misale S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Cocco E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Baldino L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Cai Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Shifman S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Tu HY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.; Myers ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Xu C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.; Mattar M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Khodos I; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Little M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Qeriqi B; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Weitsman G; Richard Dimbleby Department of Cancer Research, King's College London, London, United Kingdom.; Wilhem CJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Lalani AS; Puma Biotechnology, Los Angeles, California.; Diala I; Puma Biotechnology, Los Angeles, California.; Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Berger MF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Barber PR; Richard Dimbleby Department of Cancer Research, King's College London, London, United Kingdom.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Ng T; Richard Dimbleby Department of Cancer Research, King's College London, London, United Kingdom.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Offin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Isbell JM; Weill Cornell Medical College, New York, New York.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Jones DR; Weill Cornell Medical College, New York, New York.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Yu HA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Thyparambil S; mProbe Inc., Rockville, Maryland.; Liao WL; mProbe Inc., Rockville, Maryland.; Bhalkikar A; mProbe Inc., Rockville, Maryland.; Cecchi F; AstraZeneca, Gaithersburg, Maryland.; Hyman DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Lewis JS; Weill Cornell Medical College, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Radiochemistry and Molecular Imaging Probe Core, Memorial Sloan Kettering Cancer Center, New York, New York.; Buonocore DJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Ho AL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Razavi P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Poirier JT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Shen R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Tsurutani J; Advanced Cancer Translational Research Institute, Department of Medical Oncology, Showa University, Tokyo, Japan.; Ulaner GA; Weill Cornell Medical College, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; mProbe Inc., Rockville, Maryland.; de Stanchina E; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Rosen N; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular-Based Therapy, Memorial Sloan Kettering Cancer Center, New York, New York.; Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York.; Scaltriti M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. scaltrim@mskcc.org lib1@mskcc.org michelif@mskcc.org misales@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Molecular-Based Therapy, Memorial Sloan Kettering Cancer Center, New York, New York.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Levitt JA; Microscopy Innovation Centre, Guy's Campus, Kings College, London, SE1 1UL, UK.; Richard Dimbleby Laboratories, School of Cancer and Pharmaceutical Sciences, Guy's Campus, Kings College London, London, SE1 1UL, UK.; Poland SP; Richard Dimbleby Laboratories, School of Cancer and Pharmaceutical Sciences, Guy's Campus, Kings College London, London, SE1 1UL, UK.; Krstajic N; Institute for Microelectronics and Nanosystems, School of Engineering, College of Science and Engineering, University of Edinburgh, Edinburgh, EH9 3FB, UK.; Pfisterer K; Randall Centre for Cell and Molecular Biophysics, Guy's Campus, Kings College, London, SE1 1UL, UK.; Erdogan A; Institute for Microelectronics and Nanosystems, School of Engineering, College of Science and Engineering, University of Edinburgh, Edinburgh, EH9 3FB, UK.; Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, WC1E 6DD, UK.; Parsons M; Randall Centre for Cell and Molecular Biophysics, Guy's Campus, Kings College, London, SE1 1UL, UK.; Henderson RK; Institute for Microelectronics and Nanosystems, School of Engineering, College of Science and Engineering, University of Edinburgh, Edinburgh, EH9 3FB, UK.; Ameer-Beg SM; Richard Dimbleby Laboratories, School of Cancer and Pharmaceutical Sciences, Guy's Campus, Kings College London, London, SE1 1UL, UK. simon.ameer-beg@kcl.ac.uk.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Weitsman G; Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K.; Lawler KKelleher MTBarrett JE; †Department of Mathematics, King's College London, Strand Campus, London WC2R 2LS, U.K.; Barber PR; §Gray Institute for Radiation Oncology & Biology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.; Shamil E; Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K.; Festy F; ║Biomaterials, Biomimetics and Biophotonics Division, King's College London Dental Institute, London SE1 9RT, U.K.; Patel GFruhwirth GOHuang L; §Gray Institute for Radiation Oncology & Biology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.; Tullis ID; §Gray Institute for Radiation Oncology & Biology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.; Woodman N; ††Guy's & St. Thomas' Breast Tissue & Data Bank, King's College London, Guy's Hospital, London SE1 9RT, U.K.; Ofo E; Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K.; Ameer-Beg SM; Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, Guy's Medical School Campus, London SE1 1UL, U.K.; Irshad S; ‡‡Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital King's College London School of Medicine, London, SE1 9RT, U.K.; Condeelis J; §§Tumor Microenvironment and Metastasis Program, Albert Einstein Cancer Center, New York, NY 10461, U.S.A.; Gillett CE; ††Guy's & St. Thomas' Breast Tissue & Data Bank, King's College London, Guy's Hospital, London SE1 9RT, U.K.; Ellis PA; ¶Department of Medical Oncology, Guy's and St. Thomas Foundation Trust, London SE1 9RT, U.K.; Vojnovic BCoolen AC; †Department of Mathematics, King's College London, Strand Campus, London WC2R 2LS, U.K.; Ng T
Publisher: Portland Press On The Behalf Of The Biochemical Society Country of Publication: England NLM ID: 7506897 Publication Model: Print Cited Medium: Internet ISSN: 1470-8752 (Electronic) Linking ISSN: 03005127 NLM ISO Abbreviation: Biochem Soc Trans Subsets: MEDLINE
Academic Journal
Akerman S; Tumor Microcirculation Group, CR-UK/YCR Sheffield Cancer Research Centre, University of Sheffield, Department of Oncology, Sheffield, United Kingdom.; Fisher MDaniel RALefley DReyes-Aldasoro CCLunt SJHarris SBjorndahl MWilliams LJEvans HBarber PRPrise VEVojnovic BKanthou CTozer GM
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Barber PR
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어